Moderna
MRNA
#1338
Rank
NZ$23.20 B
Marketcap
$60.01
Share price
0.47%
Change (1 day)
-65.26%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total assets

Total assets on the balance sheet as of December 2024 : NZ$24.62 Billion

According to Moderna 's latest financial reports the company's total assets are NZ$24.62 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Moderna - Total assets on balance sheet (from 2017 to 2024)

Total assets by year

Year Total assets Change
2024-12-31NZ$25.07 B-13.94%
2023-12-31NZ$29.13 B-28.46%
2022-12-31NZ$40.72 B12.77%
2021-12-31NZ$36.11 B255.18%
2020-12-31NZ$10.16 B330.87%
2019-12-31NZ$2.36 B-19.32%
2018-12-31NZ$2.92 B91.56%
2017-12-31NZ$1.52 B-25.36%
2016-12-31NZ$2.04 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$0.16 B-99.34%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$203.94 B 728.07%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.93 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.38 B-70.02%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$178.06 B 623.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$1.76 B-92.83%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$313.65 B 1,173.54%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA